Do sleep fragmentation and obstructive sleep apnea increase fasting insulin while keeping glucose normal?

Mechanistic explanations

• Intermittent hypoxia and oxidative stress: Obstructive sleep apnea (OSA) causes recurrent, rapid cycles of arterial oxygen desaturation and reoxygenation. This intermittent hypoxia stimulates the carotid body chemoreceptors, triggering a cascade of oxidative stress, systemic inflammation, and elevated hypoxia-inducible factor 1-alpha (HIF-1α). These pathways directly impair insulin receptor substrate (IRS) signaling in skeletal muscle and adipose tissue.
• Sympathetic and endocrine activation: Both sleep fragmentation (marked by micro-arousals and disrupted sleep architecture) and intermittent hypoxia act as physical stressors. They trigger chronic sympathetic nervous system activation, leading to elevated circulating catecholamines (norepinephrine and epinephrine). Furthermore, sleep fragmentation stimulates the hypothalamic-pituitary-adrenal (HPA) axis, causing elevated nocturnal cortisol levels. Together, catecholamines and cortisol promote lipolysis (increasing free fatty acids), elevate hepatic gluconeogenesis, and directly oppose insulin action in peripheral tissues.

Clinical evidence and metabolic outcomes

• Euglycemic hyperinsulinemia: As peripheral tissue sensitivity to insulin declines due to sympathetic overactivity and hypoxia, the pancreas must compensate. Pancreatic beta-cells increase basal insulin secretion to keep blood glucose levels stable. This manifests clinically as elevated fasting insulin and an increased Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) index, even while fasting blood glucose remains within normal physiological limits (typically <100 mg/dL).
• Clinical study findings: Longitudinal cohorts and controlled sleep-restriction studies show that even a few nights of fragmented sleep can reduce peripheral insulin sensitivity by 20% to 30%. In clinical studies of OSA patients, gold-standard hyperinsulinemic-euglycemic clamp assessments confirm a strong association between the severity of nocturnal oxygen desaturation and the degree of insulin resistance, independent of body mass index (BMI).

Bottom line

Obstructive sleep apnea and sleep fragmentation drive a dual pathway of intermittent hypoxia and sympathetic/HPA-axis activation. These mechanisms directly impair insulin sensitivity, forcing the body to secrete excess fasting insulin to maintain normal blood glucose—marking an early, silent phase of metabolic dysfunction.